Children in the UK will be able to receive Palforzia – a life-changing oral treatment for peanut allergies – as NHS standard of care following approval for use by NICE.
The NIHR Immune Mediated Inflammatory Disease (IMID) BioResource recently hit a major recruitment milestone of 2000 volunteers, thanks to the collaborative effort of centres across England.
MFT Junior Doctor in Emergency Medicine Doctor, Anisa Jafar, was named Young Researcher of the Year by NIHR CRN and Royal College of Emergency Medicine.
Manchester research links two types of less-often prescribed diabetes drugs with lower chances of potentially fatal heart problems – in people with type 2 diabetes without established heart disease.
The NHS has struck a deal for a life-saving treatment that will offer babies and young children with a rare and life-limiting genetic disease the prospect of a normal life.
Researchers at Saint Mary’s Hospital will explore the effectiveness of an innovative new self-management programme for women with pelvic organ prolapse.
Researchers at The Christie and CRUK, supported by MFT's North West Genomics Laboratory Hub, are investigating a new blood test that could detect if melanoma patients are relapsing sooner.